Tech Company Financing Transactions

Neotropix Funding Round

Neotropix secured a $3.8 million venture capital round on 3/31/2006. Backers included Aurora Funds and Quaker Partners.

Transaction Overview

Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$3,800,100
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
351 Phoenixville Pike
Malvern, PA 19355
USA
Email Address
Overview
Neotropix is an early stage drug discovery company dedicated to the research, development and commercialization of virus-based therapies for the treatment of cancer. Founded in 2003, Neotropix is developing oncolytic virotherapies to treat several of the most aggressive and deadly forms of cancer.
Profile
Neotropix LinkedIn Company Profile
Social Media
Neotropix Company Twitter Account
Company News
Neotropix News
Facebook
Neotropix on Facebook
YouTube
Neotropix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Lanciano
  Peter  Lanciano LinkedIn Profile  Peter  Lanciano Twitter Account  Peter  Lanciano News  Peter  Lanciano on Facebook
Chief Scientific Officer
Paul Hallenbeck
  Paul Hallenbeck LinkedIn Profile  Paul Hallenbeck Twitter Account  Paul Hallenbeck News  Paul Hallenbeck on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2006: Blue Chip Surgical Center Partners venture capital transaction
Next: 3/31/2006: Ometric venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary